RxDoctor Payments DataLook up a doctor →

Kyle Parish, MD

Sports Medicine · Paducah, KYNPI 1881622751

Payments from drug & device makers

$9,664in general payments, 2019–2025

Across 586 payments — averaging $16.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$1K
  • AstraZeneca$1K
  • Pfizer$1K
  • Lilly USA, LLC$576
  • Novo Nordisk$522
  • plus $4K from 35 others

What the payments were for

  • Food & beverage$9,664100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,664 in reported general payments places this provider in the 85th percentile of 59 sports medicine providers in Kentucky.

See all sports medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$191,750
Medicare patients
457
Services billed
2,073

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban165$132,552
FarxigaDapagliflozin Propanediol126$102,366
JardianceEmpagliflozin64$61,956
TrulicityDulaglutide37$55,981
Soliqua 100-33Insulin Glargine/Lixisenatide36$34,003
VraylarCariprazine Hcl14$29,584
Repatha SureclickEvolocumab35$27,638
OzempicSemaglutide19$26,990
MounjaroTirzepatide24$24,542
EntrestoSacubitril/Valsartan30$22,949
RybelsusSemaglutide21$21,188
AbrysvoRsv Vacc, Pref A And Pref B/Pf65$20,779
MyrbetriqMirabegron24$20,589
XareltoRivaroxaban16$19,678
Xigduo XrDapaglifloz Propaned/Metformin19$16,507

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$1,037$153,331230 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,046$118,011145 claims
Lilly USA, LLCTrulicity, Mounjaro$576$80,52261 claims
Boehringer IngelheimJardiance$321$61,95664 claims
Novo NordiskOzempic, Rybelsus$522$48,17740 claims
AbbVieVraylar, Linzess, Synthroid$1,567$48,05189 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$375$34,00336 claims
NovartisEntresto$125$22,94930 claims
Astellas Pharma US IncMyrbetriq$71$20,58924 claims
Johnson & JohnsonXarelto$59$19,67816 claims
MerckJanumet, Belsomra$29$11,91125 claims
GSKShingrix$32$10,31246 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 59 sports medicine providers in Kentucky.

Other sports medicine in Paducah

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →